Ahead of the snap Spanish election this weekend, Chief Executive Officer of Linneo Health Don Bellamy lays out the frustrating situation for thousands of patients who are forced to turn to the black market despite a medical cannabis framework being ‘within reach’.Â
Confirmation from the Spanish government earlier this month that proposals for the rollout of a medicinal cannabis framework will not happen before the upcoming elections is a huge blow for patients.
The growing need for medicinal cannabis is a reality in Spain that we cannot avoid, and this government’s initial commitment offered thousands of people hope. From general anxiety to chronic pain or the easing of cancer symptoms, medicinal cannabis would be available, safely and securely, to patients in Spain with a wide range of conditions. This would be a win for patients.
However, with every passing day, patients in Spain remain exposed. The frustrations and anger of many that parliamentary process has brought plans to a standstill, reflect the continued unease that patients must continue to self medicate, forced to rely on cannabis products from the illegal and uncontrolled black market. This is all the more frustrating because a safe and viable alternative solution is within reach.
Spain remains one of the last European countries to legislate for the medicinal use of cannabis, lagging behind its neighbours for too long. Countries such as Germany, the United Kingdom, Portugal and Italy have established frameworks so that patients in need can access an appropriate cannabis-based therapy, from inhaled and medically cultivated dried flowers or through the consumption of specifically formulated cannabis extracts. It is lagging behind many of its European neighbours.
READ MORE: Spain Confirms No Movement On Medical Cannabis Framework Before Election, But Hope Remains It ‘Will Be Regulated In The Next Legislative Term, For Sure’
Germany’s legislation is a reference for the world, with physician monitoring of patients and follow-up through a qualified pharmacist. In the UK, tens of thousands of patients are now receiving medicinal cannabis treatment, regulated with guarantees of safety and quality.
Across the border from us, Portugal has a list of seven indications previously evaluated by a Scientific Committee with specific marketing authorisations and our other neighbour, France, is finalising a pilot program with signs showing that several indications in which medicinal cannabis will be applied for use have been selected. In every country with well thought out regulation we hear the same reaction: The patient experience is the same as for any medicinal product, which means that patient safety is paramount.
Patients in Spain deserve better, so when parliament returns after the elections, whatever parties form the next government, I hope they will be respectful to the needs of patients and deliver on the existing commitment. Spain’s parliamentarians need look no further than their European neighbours for evidence that regulation and laws can improve access to cannabis medicines and, ultimately, improve patient care.
This is a once-in-a-lifetime opportunity to deliver the right result for patients in Spain, who have been waiting for so long, while, in their own words, their pain waits for no one.
Don Bellamy is Chief Executive Officer of Linneo Health, a global leader in the research, cultivation and supply of cannabis, with European operations and cultivation facilities in Murcia, Southern Spain.
The Growing Need for Medicinal Cannabis is a Reality in Spain That Cannot be Avoided
Ahead of the snap Spanish election this weekend, Chief Executive Officer of Linneo Health Don Bellamy lays out the frustrating situation for thousands of patients who are forced to turn to the black market despite a medical cannabis framework being ‘within reach’.Â
Confirmation from the Spanish government earlier this month that proposals for the rollout of a medicinal cannabis framework will not happen before the upcoming elections is a huge blow for patients.
The growing need for medicinal cannabis is a reality in Spain that we cannot avoid, and this government’s initial commitment offered thousands of people hope. From general anxiety to chronic pain or the easing of cancer symptoms, medicinal cannabis would be available, safely and securely, to patients in Spain with a wide range of conditions. This would be a win for patients.
However, with every passing day, patients in Spain remain exposed. The frustrations and anger of many that parliamentary process has brought plans to a standstill, reflect the continued unease that patients must continue to self medicate, forced to rely on cannabis products from the illegal and uncontrolled black market. This is all the more frustrating because a safe and viable alternative solution is within reach.
Spain remains one of the last European countries to legislate for the medicinal use of cannabis, lagging behind its neighbours for too long. Countries such as Germany, the United Kingdom, Portugal and Italy have established frameworks so that patients in need can access an appropriate cannabis-based therapy, from inhaled and medically cultivated dried flowers or through the consumption of specifically formulated cannabis extracts. It is lagging behind many of its European neighbours.
READ MORE: Spain Confirms No Movement On Medical Cannabis Framework Before Election, But Hope Remains It ‘Will Be Regulated In The Next Legislative Term, For Sure’
Germany’s legislation is a reference for the world, with physician monitoring of patients and follow-up through a qualified pharmacist. In the UK, tens of thousands of patients are now receiving medicinal cannabis treatment, regulated with guarantees of safety and quality.
Across the border from us, Portugal has a list of seven indications previously evaluated by a Scientific Committee with specific marketing authorisations and our other neighbour, France, is finalising a pilot program with signs showing that several indications in which medicinal cannabis will be applied for use have been selected. In every country with well thought out regulation we hear the same reaction: The patient experience is the same as for any medicinal product, which means that patient safety is paramount.
Patients in Spain deserve better, so when parliament returns after the elections, whatever parties form the next government, I hope they will be respectful to the needs of patients and deliver on the existing commitment. Spain’s parliamentarians need look no further than their European neighbours for evidence that regulation and laws can improve access to cannabis medicines and, ultimately, improve patient care.
This is a once-in-a-lifetime opportunity to deliver the right result for patients in Spain, who have been waiting for so long, while, in their own words, their pain waits for no one.
Don Bellamy is Chief Executive Officer of Linneo Health, a global leader in the research, cultivation and supply of cannabis, with European operations and cultivation facilities in Murcia, Southern Spain.
Missouri Will Conduct Marijuana Business Demographic Survey Amid Criticism That Black People Are Being Left Out Of Industry
Next PostBill Aims to Establish Regulatory Framework for CBD as a Supplement
Business of Cannabis
Related Posts
Related Posts
Czech Republic’s Revolutionary Legislation to Regulate Psychoactive Substances Such as HHC Clears First Hurdle
The Czech Republic’s lower house has passed a proposal seeking to regulate ‘psychomodulating’ substances, which is likely to include synthetic...
Zurich Executive Summit: Unveiling the Future of Cannabis-Pharmaceutical Collaboration
The European cannabis events season is now in full swing, and this month all eyes are turning to Switzerland, one...
Proposed Amendments to the Cannabis Act (CanG) Considered Unconstitutional
UK’s Medical Cannabis Boom: Patients, Demand, and Consumption Surge to All-Time Highs – With a Record Number of Private Clinics
SynBiotic Acquires German Wholesaler Weeco as Clever Leaves & OCT Reveal Plans to Delist as Stocks Struggle
Speedy Amnesty for Cannabis Convictions in Germany
CONNECT
Related Posts
Related Posts
Czech Republic’s Revolutionary Legislation to Regulate Psychoactive Substances Such as HHC Clears First Hurdle
The Czech Republic’s lower house has passed a proposal seeking to regulate ‘psychomodulating’ substances, which is likely to include synthetic...
Zurich Executive Summit: Unveiling the Future of Cannabis-Pharmaceutical Collaboration
The European cannabis events season is now in full swing, and this month all eyes are turning to Switzerland, one...
Proposed Amendments to the Cannabis Act (CanG) Considered Unconstitutional
A series of proposed amendments to the Cannabis Act (CanG) which would further constrain cultivation associations could be brought in...
UK’s Medical Cannabis Boom: Patients, Demand, and Consumption Surge to All-Time Highs – With a Record Number of Private Clinics
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater...
SynBiotic Acquires German Wholesaler Weeco as Clever Leaves & OCT Reveal Plans to Delist as Stocks Struggle
Synbiotic German cannabis group SynBiotic has capitalised on the recent explosion in medical cannabis patients since the country’s landmark...
Recent Posts
Related Posts
Spain Publishes Draft Medical Cannabis Framework, But Omits Flower
Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country....
Spain’s Medical Cannabis Law to Be Ready ‘In the Coming Months’ Says Health Minister
Spain’s newly appointed health minister has said that the country’s long-awaited medical cannabis law will be ready ‘in the coming...
Spain Breaks Medical Cannabis Deadlock as New Health Minister Sparks Optimism
As Spain emerges from months of political deadlock, its newly formed government has at last made a meaningful commitment to...
Spain Confirms No Movement On Medical Cannabis Framework Before Election, But Hope Remains It ‘Will Be Regulated In The Next Legislative Term, For Sure’
After months of silence and delays from the Spanish government, the country’s Health Minister has confirmed that proposals for the...
What Does Spain’s Snap Election Mean For Its Long-Awaited Medical Cannabis Industry?
THE highly-anticipated regulation and roll out of a medical cannabis industry in Spain, already over 6 months overdue, is now...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags